This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Mar. 1, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.



The genetic ripple effect of hardship
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefOur experiences in life don't just affect how we learn and behave, they can also mark our genes and influence our children, a growing body of research suggests. Stressful events and drug use appear to alter how and when genes are turned off and on. Some environmental influences create such long-lasting and significant biological changes that they can be passed on to affect the health of the next generation, studies show. More

Scientists: Ovary stem cells can produce new human eggs
Time    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Although it has long been assumed that women are born with all the eggs they will ever have in a lifetime, recent research has hinted that might not be the case. Now researchers report the strongest evidence yet that women may be able to replenish their supply of eggs after they are born — and perhaps after age or disease might have normally hindered their fertility. More

Popping the genetics bubble
Canadian Medical Association Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The hype over the promise of genetics in medicine, like the superlatives that swirl around most "revolutions" in healthcare, started as genuine enthusiasm for promising technologies. It didn't take long, however, for researchers to come under pressure to make their work sound exciting, commercializable and immediately applicable. More

 Biotech/Diagnostics/Personalized Medicine

Bird flu, pig flu, now bat flu? Human risk unclear
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For the first time, scientists have found evidence of flu in bats, reporting a never-before-seen virus whose risk to humans is unclear. The surprising discovery of genetic fragments of a flu virus is the first well-documented report of it in the winged mammals. So far, scientists haven't been able to grow it, and it's not clear if — or how well — it spreads. More

British: Hip devices may harm more than breast implants
Bloomberg News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Failing metal-on-metal hip replacements made by manufacturers including Johnson & Johnson may harm more people than leaking breast implants made in France, according to an investigation by the British Medical Journal and the BBC. Hundreds of thousands of people worldwide may have been exposed to high levels of toxic cobalt and chromium ions that can seep into tissues and destroy muscle and bone, leaving some patients with long-term disability, the BMJ and BBC said. More

Rapid flu tests ease ERs, despite limits
Futurity    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An analysis of 159 studies shows rapid flu tests can be used to confirm the flu, but not to rule it out. In addition, the McGill University study says test accuracy is higher in children than it is in adults and that Rapid Influenza Diagnostic Tests are better at detecting the more common influenza A virus than they are at detecting influenza B. More

Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE

 Regenerative Medicine

Omega-3 oils good for brain health in study involving older people
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Eating fish can be good for the heart, thanks to the presence of omega-3 fatty acids. Might fish consumption help the brain, too? A study involved 1,575 adults who averaged 67 years old and had no signs of dementia and had not had a stroke. They were given MRI brain scans and a battery of tests to measure memory and thinking abilities; they also had blood drawn to check the level of omega-3 fatty acids. Those with the lowest levels of omega-3s showed signs of accelerated aging. More

Health experts want boys to get HPV vaccine
WLS-TV (ABC Chicago)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The nation's largest group of pediatricians is renewing its recommendation that boys ages 11 and up receive the three-dose HPV vaccine. Since 2006, the vaccine has been recommended for girls to prevent cervical cancer, but experts say since that time, other cancers thought to be caused by HPV have increased — including anal and some head and neck cancers. More

 Emerging Medical Technologies

Children now eligible for bacterium breath test
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration has expanded approval for a breath test that screens for a common ulcer-causing germ, to include children ages 3 years to 17 years old. The Helicobacter pylori bacterium causes stomach inflammation and ulcers, and increases an infected person's risk of gastric cancer and a certain form of lymphoma. More

FDA: Medical device loophole needs closing by Congress
Bloomberg News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration's top medical-device regulator said the agency needs more power to block unsafe products and prevent repeats of faulty hip implants and vaginal mesh that sparked thousands of lawsuits. House Democrats introduced legislation recently to let the FDA reject devices that have designs based on past products that were recalled for safety flaws. More

 Managed Healthcare News

Insurers open stores to peddle health plans
Kaiser Health News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health insurers increasingly want to make shopping for a new health plan as easy and convenient as dropping into a local retailer to buy a TV. In recent years, a number of them have opened stores where consumers can stop by to talk with a customer service representative about buying a plan or resolve questions about their current coverage. More

In vitro a fertile niche for lenders
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At a time when many traditional lenders are struggling, companies that join forces with doctors to make loans for in vitro fertilization, egg harvesting and other fertility treatments say their business is thriving. One reason: Fertility-finance companies are getting a boost from the banking industry's retrenchment. More

 FDA: New Treatments and Technology

FDA adds diabetes, memory loss warnings to statins
Reuters via Baltimore Sun    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory loss. The Food and Drug administration announced the changes to the safety information on the labels of statins such as Pfizer's Lipitor, AstraZeneca's Crestor and Merck & Co's Zocor. More

Biogen gets US approval for user-friendly MS drug
The Associated Press via Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drugmaker Biogen Idec said it received approval for an easier-to-use form of its multiple sclerosis injection Avonex. The Food and Drug Administration approved the company's Avonex pen, an injection designed to reduce pain and anxiety when patients self-administer the drug. The FDA also approved a new dosing schedule for the drug intended to reduce flu-like symptoms associated with the drug. More

"An estimated 13 million people in the United States take statins to reduce cholesterol and reduce heart disease, according to the Arthritis Foundation."
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to %%emailaddr%%. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Feb. 23, 2012
Feb. 16, 2012
Feb. 9, 2012
Feb. 2, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063